Release of PAI-1 by human preadipocytes and adipocytes independent of insulin and IGF-1

被引:17
作者
Crandall, DL [1 ]
Groeling, TM [1 ]
Busler, DE [1 ]
Antrilli, TM [1 ]
机构
[1] Wyeth Res Labs, Womens Hlth Res, Philadelphia, PA 19087 USA
关键词
plasminogen activator inhibitor-1; insulin; insulin-like growth factor I; adipose tissue; leptin; insulin resistance; cell culture;
D O I
10.1006/bbrc.2000.4045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effect of insulin and insulin-like growth factor-1 (IGF-1) on plasminogen activator inhibitor-1 (PAI-1) release from primary cultures of human preadipocytes and adipocytes has been investigated, Initial experiments measuring basal PAI-1 release (ng/ml) indicated variability between individual cultures. Using a novel technique for adipocyte quantitation, additional experiments were pet-formed to determine (PAI-1) release per cell, indicating a significant reduction with differentiation. insulin and IGF-1 over a range of concentrations had no effect on PAI-1 release, and RT-PCR of PAI-1 mRNA following treatment with insulin and IGF-1 also indicated similar expression between treatments. The cultures did exhibit insulin-stimulated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression and leptin synthesis following differentiation to the adipocyte phenotype. This is the first report of PAI-1 secretion by primary cultures of human preadipocytes and adipocytes, indicating PAI-1 release independent of insulin and IGF-I and implicating other factors in the elevated plasma PAI-1 observed with insulin resistance. (C) 2000 Academic Press.
引用
收藏
页码:984 / 988
页数:5
相关论文
共 30 条
[1]  
ALESSI MC, 1988, THROMB HAEMOSTASIS, V60, P491
[2]   Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease [J].
Alessi, MC ;
Peiretti, F ;
Morange, P ;
Henry, M ;
Nalbone, G ;
JuhanVague, I .
DIABETES, 1997, 46 (05) :860-867
[3]  
ALEXANDER M, 1985, J BIOL CHEM, V260, P1978
[4]  
BASTARD JP, 1995, INT J OBESITY, V19, P838
[5]   Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation [J].
Boney, CM ;
Smith, RM ;
Gruppuso, PA .
ENDOCRINOLOGY, 1998, 139 (04) :1638-1644
[6]  
Chambers SK, 1998, INT J CANCER, V79, P449
[7]   Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes [J].
Crandall, DL ;
Quinet, EM ;
Morgan, GA ;
Busler, DE ;
McHendry-Rinde, B ;
Kral, JG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (09) :3222-3227
[8]   Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals [J].
Eriksson, P ;
Reynisdottir, S ;
Lönnqvist, F ;
Stemme, V ;
Hamsten, A ;
Arner, P .
DIABETOLOGIA, 1998, 41 (01) :65-71
[9]   Sex steroids regulate the expression of plasminogen activator inhibitor-1 (PAI-1) and its mRNA in uterine endometrial cancer cell line Ishikawa [J].
Fujimoto, J ;
Hori, M ;
Ichigo, S ;
Tamaya, T .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 59 (01) :1-8
[10]   Troglitazone reduces plasminogen activator inhibitor-1 expression and secretion in cultured human adipocytes [J].
Gottschling-Zeller, H ;
Röhrig, K ;
Hauner, H .
DIABETOLOGIA, 2000, 43 (03) :377-383